Therefore, TIGIT is a pivotal inhibitory immune checkpoint that its high expression in tumoral cells and cells residing in the tumor microenvironment can remarkably attenuate anti-tumoral immune responses. The gene discussed is TIGIT; the disease is neoplasm.